Disclosure Plus

HENG SHENG GROUP COMPANY LIMITED Decides on 5.2 Billion Won Third-Party Private Placement

KIM YOON-JEONG
2026-08-19 15:05:02
[Edaily Reporter KIM YOON-JEONG ] HENG SHENG GROUP COMPANY LIMITED(900270)announced on the 19th that it has decided to conduct a third-party private placement worth 5.24805 billion won to raise operating funds.
The number of new shares to be issued is 1,749,353 common shares, with an issue price of 2,100 won per share.
The recipient of the third-party allocation is the largest shareholder, Hui Mei Nga, and the new shares will be subject to a lock-up period for one year following issuance.
The payment date is the 27th, and the new shares are scheduled to be listed on September 23.

Economy

Corporation

IT·Science

Economy

Samsung to Break Ground This Month on Yongin National Semiconductor Industrial Complex… Unveils Blueprint to Local Residents

Construction on the Yongin National Industrial Complex for Advanced System Semiconductors, a project involving an investment of approximately 360 trillion won by SamsungElectronics, is set to begin th…
2026-10-04 06:00:03
"600 Billion Won from a Single Pixel Game"... The Next Move by a 13-Year-Old Game Developer [VC Cradle]
2026-10-03 16:06:03
Sold the House, but the Money and People Stayed the Same… The Secret of “2 Minutes and 13 Seconds” [Taxes, What Happens Next]
2026-10-03 00:07:01

Corporation

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
2026-10-03 07:22:03
G.I. Innovation and G2G Rise 20% on Expectations of Technology Exports [Bio Spotlight]
2026-10-03 07:22:02
“AI Generates Candidate Compounds, PROTEINA CO., LTD. Validates Them”… Targeting the ‘Wet Lab’ Bottleneck in New Drug Development [Invest Bio]
2026-10-03 06:01:02

IT·Science

Jeong Sang-won, CEO of Embricks: “Realizing In-Body CAR-T”… The Secret to Weathering the Investment Slump

(Graphic: ChatGPT) “While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…
2026-10-04 07:32:02
A-Sleep Partners with Hyundai Engineering & Construction and Samsung Electronics on 'Sleep Orchestra'… "We Will Create a Wall Pad for the Bedroom"
2026-10-04 07:02:03
CEO Cha Sang-hoon, Who Stepped Down from Management: Will He Prove the Value of “SAFA” Through “APB-R3”? [Bio Industry Figures in the Spotlight]
2026-10-03 17:01:02